ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

Fischinger Names HHS AIDs Coordinator; DeVita Appoints Maryann Roper Acting Deputy Director

October 30, 1987

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

December 26, 2003

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

In Brief; Jerome Green To Head NIH Div. Of Research Grants; M.D. Anderson’s Even Hersh To Join Univ. of Arizona

December 13, 1985

In Brief: While House Floats Healy’s Name For NIH Post; USC To Enhance Norris Center With NCI Grants

September 14, 1990